Truncation of human squalene synthase yields active, crystallizable protein.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Archives of Biochemistry and Biophysics

• Publication date

  1998-02-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1006/ABBI.1997.0502PMID 9473303
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Squalene synthetase

  2004cited by this paper
• 3-(4-chlorophenyl)-2-(4-diethylaminoethoxyphenyl)-A-pentenonitrile monohydrogen citrate and related analogs. Reversible, competitive, first half-reaction squalene synthetase inhibitors.

  1997cited by this paper
• RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductase.

  1997cited by this paper
• Molecular cloning and functional expression of a cDNA for mouse squalene synthase.

  1995cited by this paper
• Expression, purification, and characterization of the human squalene synthase: use of yeast and baculoviral systems.

  1995cited by this paper
• Inhibition of Mammalian Squalene Synthetase Activity by Zaragozic Acid A Is a Result of Competitive Inhibition Followed by Mechanism-based Irreversible Inactivation

  1995cited by this paper
• Protein farnesyltransferase: measurement of enzymatic activity in 96-well format using TopCount microplate scintillation counting technology.

  1995cited by this paper
• Comparative study of the inhibition of rat and tobacco squalene synthase by squalestatins.

  1995cited by this paper
• A Mammalian Activity Required for the Second Step of Pre-messenger RNA Splicing (*)

  1995cited by this paper
• Cloning, expression, and characterization of cDNAs encoding Arabidopsis thaliana squalene synthase.

  1995cited by this paper
• Lipophilic 1,1-bisphosphonates are potent squalene synthase inhibitors and orally active cholesterol lowering agents in vivo.

  1993cited by this paper
• Identification and regulation of rat squalene synthetase mRNA.

  1993cited by this paper
• Cloning, expression and characterisation of the cDNA encoding human hepatic squalene synthase, and its relationship to phytoene synthase.

  1993cited by this paper
• Yeast squalene synthase: expression, purification, and characterization of soluble recombinant enzyme.

  1993cited by this paper
• Overexpression, purification, and kinetic characterization of a carboxyl-terminal-truncated yeast squalene synthetase.

  1993cited by this paper
• Transcriptional regulation by lovastatin and 25-hydroxycholesterol in HepG2 cells and molecular cloning and expression of the cDNA for the human hepatic squalene synthase.

  1993cited by this paper
• Zaragozic acids: a family of fungal metabolites that are picomolar competitive inhibitors of squalene synthase.

  1993cited by this paper
• Conservation between human and fungal squalene synthetases: similarities in structure, function, and regulation

  1993cited by this paper
• Squalestatin 1, a potent inhibitor of squalene synthase, which lowers serum cholesterol in vivo.

  1992cited by this paper
• Solubilization, purification, and characterization of a truncated form of rat hepatic squalene synthetase.

  1992cited by this paper
• Molecular cloning, expression, and characterization of the cDNA for the rat hepatic squalene synthase.

  1992cited by this paper
• Sparse matrix sampling: a screening method for crystallization of proteins

  1991cited by this paper
• Molecular cloning and characterization of the yeast gene for squalene synthetase.

  1991cited by this paper
• Isolation and primary structure of the ERG9 gene of Saccharomyces cerevisiae encoding squalene synthetase

  1991cited by this paper
• Regulation of the mevalonate pathway

  1990cited by this paper
• Biosynthesis of non-head-to-tail terpenes. Formation of 1'-1 and 1'-3 linkages

  1990cited by this paper
• Posttranslational modification of proteins by isoprenoids in mammalian cells

  1990cited by this paper
• Biosynthesis of Isoprenoid Compounds

  1983cited by this paper
• Regulation of HMG-CoA reductase.

  1976cited by this paper
• Third International Symposium on Drugs Affecting Lipid Metabolism

  1969cited by this paper

• Selenocyanate‐Containing Molecules as Trypanosoma cruzi Inhibitors: Impact of Regioisomerism, Conformational Restriction, and Second‐Ring Substitution

  2025cites this paper
• Unveiling the Therapeutic Potential of Squalene Synthase: Deciphering Its Biochemical Mechanism, Disease Implications, and Intriguing Ties to Ferroptosis

  2023cites this paper
• Lanosterol biosynthesis pathway in GtoPdb v.2023.1

  2023cites this paper
• Identification of non-conventional small molecule degraders and stabilizers of squalene synthase

  2023cites this paper
• Structural Basis for the Prenylation Reaction of Carbazole-Containing Natural Products Catalyzed by Squalene Synthase-like Enzymes.

  2022cites this paper
• A Structural and Bioinformatics Investigation of a Fungal Squalene Synthase and Comparisons with Other Membrane Proteins

  2022cites this paper
• Bisphosphonate inhibitors of squalene synthase protect cells against cholesterol‐dependent cytolysins

  2021cites this paper
• Microbial Bioprocess for Extracellular Squalene Production and Formulation of Nanoemulsions

  2021cites this paper
• Production of C20, C30 and C40 terpenes in the engineered phototrophic bacterium Rhodobacter capsulatus.

  2021cites this paper
• Production of Squalene in Bacillus subtilis by Squalene Synthase Screening and Metabolic Engineering

  2020cites this paper
• Using Engineered Escherichia coli to Synthesize Squalene with Optimized Manipulation of Squalene Synthase and Mevalonate Pathway

  2020cites this paper
• Extension of cell membrane boosting squalene production in the engineered Escherichia coli

  2020cites this paper
• Lanosterol biosynthesis pathway (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• Construction of a pathway to C50-ε-carotene

  2019cites this paper
• Studies with Guanidinium- and Amidinium-Based Inhibitors Suggest Minimal Stabilization of Allylic Carbocation Intermediates by Dehydrosqualene and Squalene Synthases.

  2018cites this paper
• Selenium-containing analogues of WC-9 are extremely potent inhibitors of Trypanosoma cruzi proliferation.

  2017cites this paper
• Molecular and biochemical characterization of squalene synthase from Siraitia grosvenorii

  2017cites this paper
• Evolution, structure and membrane association of NDUFAF6, an assembly factor for NADH:ubiquinone oxidoreductase (Complex I).

  2017cites this paper
• A squalene synthase protein degradation method for improved sesquiterpene production in Saccharomyces cerevisiae.

  2017cites this paper
• Production of squalene by microbes: an update

  2016cites this paper
• Production of squalene by microbes: an update

  2016cites this paper
• Production of squalene by squalene synthases and their truncated mutants in Escherichia coli.

  2015cites this paper
• Directed optimization of a newly identified squalene synthase from Mortierella alpine based on sequence truncation and site-directed mutagenesis

  2015cites this paper
• Biosynthesis of Squalene from Farnesyl Diphosphate in Bacteria: Three Steps Catalyzed by Three Enzymes

  2015cites this paper
• Exploration of Peptide Inhibitors of Human Squalene Synthase through Molecular Modeling and Phage Display Technique

  2015cites this paper
• Triterpenoid profiling and functional characterization of the initial genes involved in isoprenoid biosynthesis in neem (Azadirachta indica)

  2015cites this paper
• Construction of carotenoid biosynthetic pathways using squalene synthase

  2014cites this paper
• Biochemical characterization of the water‐soluble squalene synthase from Methylococcus capsulatus and the functional analyses of its two DXXD(E)D motifs and the highly conserved aromatic amino acid residues

  2014cites this paper
• Molecular cloning and differential expression analysis of a squalene synthase gene from Dioscoreazingiberensis, an important pharmaceutical plant

  2014cites this paper
• Directed evolution of squalene synthase for dehydrosqualene biosynthesis

  2014cites this paper
• Cloning, expression and characterization of squalene synthase from Inonotus obliquus

  2013influential citation
• The Concise Guide to Pharmacology 2013/14: Enzymes

  2013cites this paper
• Molecular Docking Studies of Squalen Synthase Inhibitors as Potential Anti Cardiovascular Disease Drugs: Insights into Drug-Protein Interaction Discovery

  2013cites this paper
• Molecular and biochemical characterization of hydrocarbon production in the green microalga Botryococcus braunii

  2012cites this paper
• Binding Modes of Zaragozic Acid A to Human Squalene Synthase and Staphylococcal Dehydrosqualene Synthase*

  2012cites this paper
• Kinetic Mechanisms of Cholesterol Synthesis: A Review

  2011cites this paper
• Enantioselective inhibition of squalene synthase by aziridine analogues of presqualene diphosphate.

  2010cites this paper
• Sterol Biosynthesis Pathway as Target for Anti-trypanosomatid Drugs

  2009cites this paper
• Cloning, Solubilization, and Characterization of Squalene Synthase from Thermosynechococcus elongatus BP-1

  2008cites this paper
• Quinuclidine Derivatives as Potential Antiparasitics

  2007cites this paper
• Molecular cloning and characterization of the yew gene encoding squalene synthase from Taxus cuspidata.

  2007cites this paper
• Kinetic Characterization of Squalene Synthase from Trypanosoma cruzi: Selective Inhibition by Quinuclidine Derivatives

  2007influential citation
• Identification and Functional Characterization of a Presqualene Diphosphate Phosphatase*

  2006cites this paper
• A suite of parallel vectors for baculovirus expression.

  2006cites this paper
• Lanosterol synthase mutations cause cholesterol deficiency-associated cataracts in the Shumiya cataract rat.

  2006cites this paper
• Effects of squalene synthase inhibitors on the growth and ultrastructure of Trypanosoma cruzi.

  2004cites this paper
• Synthesis of novel 4,1-benzoxazepine derivatives as squalene synthase inhibitors and their inhibition of cholesterol synthesis.

  2002cites this paper
• Syntheses of fused heterocyclic compounds and their inhibitory activities for squalene synthase.

  2002cites this paper
• Squalene synthase as a chemotherapeutic target in Trypanosoma cruzi and Leishmania mexicana.

  2002cites this paper
• Biosynthetic Routes Diverting from Intermediates of Isoprenoid Biosynthesis to Related Products of the Metabolism

  2001cites this paper
• Squalene synthase: structure and regulation.

  2001cites this paper
• Crystal Structure of Human Squalene Synthase

  2000cites this paper
• Lanosterol 14alpha-demethylase (CYP51), NADPH-cytochrome P450 reductase and squalene synthase in spermatogenesis: late spermatids of the rat express proteins needed to synthesize follicular fluid meiosis activating sterol.

  2000cites this paper
• Squalene synthase: steady-state, pre-steady-state, and isotope-trapping studies.

  2000cites this paper
• A crystallizable form of RIIbeta regulatory domain obtained by limited proteolysis.

  2000cites this paper
• HMG-CoA reductase regulation: use of structurally diverse first half-reaction squalene synthetase inhibitors to characterize the site of mevalonate-derived nonsterol regulator production in cultured IM-9 cells.

  1999cites this paper